← Eichor
Condition: Cirrhosis Liver Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Cirrhosis Liver

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study
NA · 11 location(s) · Pharmicell Co., Ltd. · NCT05093881Clinical Efficacy and Population Pharmacokinetics of β-lactams in Cirrhotic Patients
Phase N/A · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT07612163Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
NA · 2 location(s) · University of Pennsylvania · NCT06136221Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese
Phase N/A · 1 location(s) · Ruijin Hospital · NCT05870969Fenofibrate in Primary Biliary Cholangitis: a Real World Study
Phase 3 · 1 location(s) · Xijing Hospital of Digestive Diseases · NCT06755151EGCG for Hepatocellular Carcinoma Chemoprevention
Phase 2 · 1 location(s) · University of Texas Southwestern Medical Center · NCT06015022Liver Damage and Cardiometabolic Disorders in NAFLD
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04036357Hospital @ Home Model of Care for Cirrhosis
NA · 1 location(s) · Indiana University · NCT06396897A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
Phase 3 · 186 location(s) · Ipsen · NCT06016842Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Phase N/A · 2 location(s) · University Medical Center Groningen · NCT07585890Microplastics, Cirrhosis and Portal Hypertension
Phase N/A · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07280390Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT06825559Efficacy of Esmolol in the Identification of Cardiovascular Disorders by Cirrhosis, Diabetes Mellitus and Cardiotoxic Tr
Phase 3 · 6 location(s) · Consorcio Centro de Investigación Biomédica en Red (CIBER) · NCT05769868Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis
NA · 1 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07286643Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
NA · 2 location(s) · Shanxi Provincial People's Hospital · NCT071160962D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices
Phase N/A · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT07122622Copper Supplementation in Cirrhosis
NA · 1 location(s) · University of Washington · NCT07471542Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Phase 2 · 13 location(s) · National Institute of Diabetes and Digestive and Kidney Dise · NCT05832229Muscle Mass Via UltraSound in Cirrhosis (MMUSCLE)
Phase N/A · 1 location(s) · University Hospital, Antwerp · NCT06345547Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome
Phase N/A · 1 location(s) · Chungnam National University Hospital · NCT06519162Biochemical Response and Clinical Outcomes in Patients With PBC
Phase N/A · 1 location(s) · RenJi Hospital · NCT07449793EUS-guided Response Assessment to NSBB
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06513195EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endosc
NA · 1 location(s) · Chinese University of Hong Kong · NCT05597488VACcination of LIver Transplantation Candidates
Phase N/A · 1 location(s) · Hospices Civils de Lyon · NCT04446832Blood Collection Biorepository for Liver Disease Research
Phase N/A · 1 location(s) · State University of New York at Buffalo · NCT03025074Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · 205 location(s) · Gilead Sciences · NCT06051617CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05623150Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Phase 4 · 1 location(s) · Mansoura University · NCT07132515Effect of HFNC on Incidence of Hypoxia During Sedated Gastrointestinal Endoscopy in Critical Patients
NA · 3 location(s) · Zhejiang University · NCT07252102
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.